Gwen Melincoff
Director/Board Member at GAIN THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Heffernan | M | 59 | 22 years | |
| Anish Bhatnagar | M | 56 | 18 years | |
| Matthias Alder | M | 59 | 3 years | |
| Eyal Rubin | M | 48 | 5 years | |
| Gianluca Fuggetta | M | 35 | 2 years | |
| Ernest Mario | M | 85 | 17 years | |
| Dror Bashan | M | 57 | 5 years | |
| Shirley Kuhlmann | F | 40 | 6 years | |
| Scott Sudduth | M | - | 6 years | |
| Scott Dreyer | M | 52 | 6 years | |
| Manolo Bellotto | M | 53 | 6 years | |
| Neil McFarlane | M | 51 | 2 years | |
| Rita Balice-Gordon | M | 63 | 4 years | |
| Shmuel Ben Zvi | M | 64 | 2 years | |
| David B. Matias | M | - |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022. | - |
| Matthew Pauls | M | 53 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Birgitte Volck | M | 61 | 5 years | |
| Daniel Schneider | M | - | 6 years | |
| Dov Goldstein | M | 56 | 3 years | |
| Claude Nicaise | M | 71 | 3 years | |
| Yaron Naos | M | 60 | 20 years | |
| Andrew Sinclair | M | 52 | 6 years | |
| Donald E. Nickelson | M | 91 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 21 years |
| Hans-Peter Hasler | M | 68 | 3 years | |
| Jeffrey Riley | M | 61 | 5 years | |
| Pol Boudes | M | 67 | 5 years | |
| Claude H. Nash | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 24 years |
| Bill Harris | M | 65 | 10 years | |
| Johanna Holldack | M | - | 7 years | |
| Eliot Forster | M | 58 | 1 years | |
| Eric Richman | M | 63 | 4 years | |
| Gino Santini | M | 66 | 12 years | |
| John Freund | M | 70 | 10 years | |
| Khalid Islam | M | 67 | 7 years | |
| John Fallon | M | 76 | 8 years | |
| Chaime Orlev | M | 53 | 7 years | |
| Aharon Schwartz | M | 80 | 10 years | |
| Amos Bar Shalev | M | 71 | 16 years | |
| Garen Bohlin | M | 76 | 9 years | |
| Elena Cubero-Jorda | F | - | - | |
| Yael Hayon | M | 41 | 4 years | |
| Maja Bergmann | F | - | 5 years | |
| Charles Horn | M | - | 2 years | |
| Fellous Yael | F | - | 2 years | |
| Kelly Clements | F | - | 2 years | |
| Christopher James | M | - | 1 years | |
| Geoffrey Coy | M | - | 5 years | |
| Colleen Tupper | F | 48 | 3 years | |
| Meredith S. Manning | F | - | - | |
| Lauren Budesheim | F | - | - | |
| Patricia Hirano | F | 58 | 7 years | |
| Arun Padmanabhan | M | - | 7 years | |
| Kristen Yen | F | 55 | 18 years | |
| David P. Geoghegan | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 20 years |
| Thomas Smith | M | 63 | 2 years | |
| Neil M. Cowen | M | - | 7 years | |
| James Mackaness | M | 60 | 5 years | |
| Gina Balderas | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Dougherty | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 years |
| Joseph Ciaffoni | M | 53 | 7 years | |
| Bruce Peacock | M | 72 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 years |
| Matthew Gantz | M | 59 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | 7 years |
| Zeev Bronfeld | M | 71 | 17 years | |
| Michael Metzger | M | 53 | - | |
| Kjetil Hestdal | M | 64 | 21 years | |
| Ambrose Bailey | M | 60 | - | |
| Yoseph Shaaltiel | M | 71 | 27 years | |
| Samuel Rubinstein | M | 59 | 2 years | |
| Saadia Ozeri | M | 54 | 13 years | |
| Raul Chertkoff | M | - | - | |
| William Taylor | M | - | 7 years | |
| Jonathan R. Wolter | M | 73 | 2 years | |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Ruth Wolfson | M | 77 | 14 years | |
| Alison B. Fleming | M | 49 | 19 years | |
| Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Anne Hovi Worsøe | F | 60 | - | |
| Synne Hermansen Røine | F | 45 | 6 years | |
| Jan Hendrik Egberts | M | 65 | 6 years | |
| Salvatore Calabrese | M | 54 | 3 years | |
| Michael DeGeorge | M | - | 7 years | |
| Anders Tuv | M | 46 | - | |
| Ian Clements | M | 55 | 1 years | |
| Gil Efron | M | 57 | 6 years | |
| Patrick Heron | M | 53 | 1 years | |
| William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Jeffrey Cooper | M | 68 | 1 years | |
| Avri Havron | M | 76 | 8 years | |
| Stuart J. M. Collinson | M | 64 | 3 years | |
| Eckard Weber | M | 73 | 1 years | |
| George V. Hager | M | 68 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
| Dennis Podlesak | M | 66 | 1 years | |
| Mahendra Shah | M | 79 | 1 years | |
| Laurent Fischer | M | 60 | 1 years | |
| Theodore Schroeder | M | 69 | 5 years | |
| Tom Edward Pike | M | 64 | 6 years | |
| Pierre Legault | M | 63 | 2 years | |
| Itzhak Krinsky | M | 71 | 2 years | |
| Paul Brannelly | M | 51 | 6 years | |
| Asaf Yosef Frumerman | M | 39 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 82.00% |
| Norway | 10 | 10.00% |
| Israel | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gwen Melincoff
- Personal Network
